Hierarchical Composite Scaffold with Deferoxamine Delivery System to Promote Bone Regeneration via Optimizing Angiogenesis
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202304232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Raokaijuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Stomatology Sichuan University, State Key Laboratory of Oral Diseases/National Clinical Research Center for Oral Diseases, Cheng…. Hauptthemen laut MEDLINE: Deferoxamine, Bone Regeneration, Tissue Scaffolds, Osteogenesis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A bone defect refers to the loss of bone tissue caused by trauma or lesion. Bone defects result in high morbidity and deformity rates worldwide. Autologous bone grafting has been widely applied in clinics as the gold standard of treatment; however, it has limitations. Hence, bone tissue engineering has been proposed and developed as a novel therapeutic strategy for treating bone defects. Rapid and effective vascularization is essential for bone regeneration. In this study, a hierarchical composite scaffold with deferoxamine (DFO) delivery system, DFO@GMs‐pDA/PCL‐HNTs (DGPN), is developed, focusing on vascularized bone regeneration. The hierarchical structure of DGPN imitates the microstructure of natural bone and interacts with the local extracellular matrix, facilitating cell adhesion and proliferation. The addition of 1 wt% of halloysite nanotubes (HNTs) improves the material properties. Hydrophilic and functional groups conferred by polydopamine (pDA) modifications strengthen the scaffold bioactivity. Gelatin microspheres (GMs) protect the pharmacological activity of DFO, achieving local application and sustained release for 7 days. DFO effectively promotes angiogenesis by activating the signaling pathway of hypoxia inducible factor‐1 α. In addition, DFO synergizes with HNTs to promote osteogenic differentiation and matrix mineralization. These results indicate that DGPN promotes bone regeneration and accelerates cranial defect healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West China School of Stomatology Sichuan University, State Key Laboratory of Oral Diseases/National Clinical Research Center for Oral Diseases, Chengdu, 610041, China.
- Liver Transplant Center and Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
- College of Polymer Science and Engineering, Sichuan University, Chengdu, 610065, China.
- Department of Orthodontics, West China School of Stomatology Sichuan University, State Key Laboratory of Oral Diseases/National Clinical Research Center for Oral Diseases, Chengdu, 610041, China.
ORCID-Profile: Raokaijuan Wang, Wei Yang, Lixing Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, R., Zha, X., Chen, J., Fu, R., Fu, Y., Xiang, J., Yang, W., & Zhao, L. (2024). Hierarchical Composite Scaffold with Deferoxamine Delivery System to Promote Bone Regeneration via Optimizing Angiogenesis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304232
Vancouver
Wang R, Zha X, Chen J, Fu R, Fu Y, Xiang J, et al. Hierarchical Composite Scaffold with Deferoxamine Delivery System to Promote Bone Regeneration via Optimizing Angiogenesis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304232
BibTeX
@article{Wang2024,
author = {Wang, Raokaijuan and Zha, Xiangjun and Chen, Jouchen and Fu, Ruijie and Fu, Yajun and Xiang, Jie and Yang, Wei and Zhao, Lixing},
title = {Hierarchical Composite Scaffold with Deferoxamine Delivery System to Promote Bone Regeneration via Optimizing Angiogenesis},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202304232}
}
EUVIMED